Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(9):641; doi:10.1093/jnci/96.9.641-a
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content

© 2004 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

MCL-1 Promoter Insertions and Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is caused by an accumulation of malignant lymphocytes that fail to undergo programmed cell death. High expression of the Mcl-1 protein, a member of the Bcl-2 family of apoptosis regulators, is associated with pathogenesis of CLL. To investigate the mechanism of altered Mcl-1 expression in CLL, Moshynska et al. (p. 673) sequenced the MCL-1 gene from peripheral blood lymphocytes of 58 CLL patients and 18 control subjects and analyzed mRNA and protein expression in a subset of patients. Seventeen of the patients but . . . [Full Text of this Article]

DNAzyme Targeting of c-Jun

Nano-Sized Contrast Agent for Visualizing Lymphatic Drainage

Selenium and Prostate Cancer Risk

Skin Cancer, Non-Hodgkin Lymphoma, and Use of Systemic Glucocorticoids

Apoptosis as a Target for Chemoprevention